S-EPMC12375827 - Multinational cost-effectiveness analysis of pembrolizumab combined with chemotherapy as first-line treatment for advanced biliary tract cancer - OmicsDI

Unknown

Dataset Information

Multinational cost-effectiveness analysis of pembrolizumab combined with chemotherapy as first-line treatment for advanced biliary tract cancer

ABSTRACT:

SUBMITTER: Xie Y

PROVIDER: S-EPMC12375827 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature